AIM ImmunoTech's total assets for Q2 2025 were $4.13M, a decrease of -33.91% from the previous quarter. AIM total liabilities were $10.68M for the fiscal quarter, a 5.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.